中文 | English
Return
Total: 44 , 1/5
Show Home Prev Next End page: GO
Author:(Xiaoguang FU)

1.Stem cell therapy for amyotrophic lateral sclerosis:cell source,number,modification,and administration route

Wen ZHAO ; Yulin BI ; Xuyang FU ; Hongmei DUAN ; Zhaoyang YANG ; Xiaoguang LI

Chinese Journal of Tissue Engineering Research 2025;29(19):4083-4090

2.Results and Analysis of National Health Accounts in 2023 in China

Yan LI ; Peipei CHAI ; Jing FENG ; Feng GUO ; Tiemin ZHAI ; Xiaoguang FU ; Quan WAN

Chinese Health Economics 2025;44(2):1-6

3.The correlation between SARS-CoV-2 B.1.1.7 nucleocapsid protein mutation with host innate immune response and clinical manifestation of COVID-19

Xianzhen HE ; Ya'nan FU ; Wanling YOU ; Aohua GENG ; Xiaoguang SUN ; Feng ZENG ; Long LIU

Tianjin Medical Journal 2025;53(12):1240-1245

4.Healthcare institution resilience and the influencing factors during infectious disease outbreaks

Yaqun FU ; Jiawei ZHANG ; Bing HAN ; Quan WANG ; Zheng ZHU ; Zhijie NIE ; Yiyang TAN ; Qing LIU ; Xiaoguang LI ; Jing GUO ; Rongmeng JIANG ; Li YANG

Journal of Peking University(Health Sciences) 2025;57(3):529-536

5.Approaches of Foshan Traumatology and Bone-Setting School to the Prevention and Treatment of Splint-Associated Pressure Ulcers in Fracture Patients

Guoxin YAN ; Mingyun FU ; Xiaoguang LIN ; Zhenlin BU ; Ruikun YAN ; Jianlin PENG

Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(11):2893-2898

6.Healthcare institution resilience and the influencing factors during infectious disease outbreaks

Yaqun FU ; Jiawei ZHANG ; Bing HAN ; Quan WANG ; Zheng ZHU ; Zhijie NIE ; Yiyang TAN ; Qing LIU ; Xiaoguang LI ; Jing GUO ; Rongmeng JIANG ; Li YANG

Journal of Peking University(Health Sciences) 2025;57(3):529-536

7.The correlation between SARS-CoV-2 B.1.1.7 nucleocapsid protein mutation with host innate immune response and clinical manifestation of COVID-19

Xianzhen HE ; Ya'nan FU ; Wanling YOU ; Aohua GENG ; Xiaoguang SUN ; Feng ZENG ; Long LIU

Tianjin Medical Journal 2025;53(12):1240-1245

8.Results and Analysis of National Health Accounts in 2023 in China

Yan LI ; Peipei CHAI ; Jing FENG ; Feng GUO ; Tiemin ZHAI ; Xiaoguang FU ; Quan WAN

Chinese Health Economics 2025;44(2):1-6

9.Evaluation of analgesic effect of nalbuphine in patients with non-mechanical ventilation in intensive care unit: a multi-center randomized controlled trail

Yi ZHOU ; Shaohua LIU ; Song QIN ; Guoxiu ZHANG ; Yibin LU ; Xiaoguang DUAN ; Haixu WANG ; Ruifang ZHANG ; Shuguang ZHANG ; Yonggang LUO ; Yu FANG ; Xiaoyun FU ; Tao CHEN ; Lening REN ; Tongwen SUN

Chinese Journal of Emergency Medicine 2024;33(1):59-64

10.The value of peripheral blood sIL-2R,CD4+/CD8+and TNF-α in evaluating the efficacy of chemotherapy in elderly patients with newly treated active pulmonary tuberculosis

Hui LIU ; Jiangyan GAO ; Lin HUO ; Xiaoguang ZHANG ; Huixiao ZHANG ; Huan ZHANG ; Hongyi FU ; Xianlei WANG ; Hejuan AN ; Yong WANG ; Rui LIU ; Suli CHEN ; Weihong LI

International Journal of Laboratory Medicine 2024;45(6):738-743,750

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 44 , 1/5 Show Home Prev Next End page: GO